Infants' expectations of the world around them have been extensively assessed through the violation of expectation paradigm and related habituation tasks. Typically, in these tasks, longer looking to impossible events following familiarisation with possible equivalents is taken to reflect surprise at their occurrence, thus revealing infants' knowledge. In this study, the role of learning during the task itself is explored by switching the archetypal approach on its head and familiarising infants to impossible events. In a partial replication of Jackson and Sirois (2009), nine-month-old infants were presented with short video clips of toy trains moving around a circular track. A tunnel over a short section of the track meant trains were briefly occluded as they completed a circuit. In impossible versions of events, the train switched colours while occluded by the tunnel. Both looking times and pupil dilation were used as dependent measures. Using a factorial design in which perceptual (novelty-familiarity) and conceptual (possible-impossible) variables were independently and jointly analysed, we show that infants showed greater responding to possible events than to impossible events following familiarisation. Pupil dilation data successfully allowed for more precise interpretation of infants' perception of events than could have been achieved through looking times alone. These findings suggest a central role for learning in violation of expectation tasks, and also further support the use of pupil dilation as a dependent measure in infancy work.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.infbeh.2022.101710 | DOI Listing |
PLoS One
January 2025
Department of Computer Engineering, Sharif University of Technology, Tehran, Iran.
Neuromorphic engineering has emerged as a promising avenue for developing brain-inspired computational systems. However, conventional electronic AI-based processors often encounter challenges related to processing speed and thermal dissipation. As an alternative, optical implementations of such processors have been proposed, capitalizing on the intrinsic information-processing capabilities of light.
View Article and Find Full Text PDFDrug Discov Ther
January 2025
Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
Cancer Genomics Proteomics
December 2024
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Background/aim: Neurofibromatosis type 1 (NF1) is a genetic disorder with an incidence of approximately one in 3,000. More than half of the patients have new de novo pathogenic variants of the NF1 gene. In most family cases, all family members share an identical NF1-variant.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
January 2025
Service of Neurology, Hospital Clinic, Barcelona, Spain.
Anti-IgLON5 disease was identified 10 years ago, thanks to the discovery of IgLON5 antibodies and the joint effort of specialists in sleep medicine, neuroimmunology, and neuropathology. Without this collaboration, it would have been impossible to untangle fundamental aspects of this disease. After the seminal description in 2014, today there is growing evidence that most patients present a chronic progressive course with gait instability, abnormal movements, bulbar dysfunction, and a sleep disorder characterized by nonrapid eye movement and REM parasomnias, and obstructive sleep apnea with stridor.
View Article and Find Full Text PDFSAGE Open Med
December 2024
Teleflex Incorporated, Morrisville, NC, USA.
Background: To demonstrate the safety and performance of the Arrow EZ-IO Intraosseous Vascular Access System, particularly in the pediatric patient population, a retrospective observational study was conducted in 2021 and 2022.
Methods: Following study design, IRB approval, and investigator selection, data were collected for all patients needing intraosseous access-adult and pediatric. The primary endpoint was the success rate for achieving intraosseous access; the secondary endpoint was the rate of adverse events.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!